Literature DB >> 28921521

A paradigm for evaluation and management of the maxillary sinus before dental implantation.

Yi-Wei Chen1,2, Fu-Ying Lee3,2, Po-Hung Chang1,2, Chi-Che Huang1,2, Chia-Hsiang Fu1,2, Chien-Chia Huang1,2, Ta-Jen Lee1,2,4.   

Abstract

OBJECTIVES: To determine a paradigm for evaluating and managing maxillary sinus conditions before dental implantation via preoperative sinonasal assessment. STUDY
DESIGN: Prospective cohort study.
METHODS: Eighty-four patients who underwent dental implantation with or without sinus augmentation were included. Maxillary sinus conditions were classified into groups 1 to 6 according to cone-beam computed tomography (CT) findings: 1) nonspecific findings, 2) solitary polyp or cyst, 3) mucosal thickening, 4) air-fluid level or fluid accumulation, 5) near-total opacification of the maxillary or other paranasal sinus, and 6) calcification spots in the maxillary sinus. Dental implantation with or without sinus augmentation was suggested with postoperative sinus observation (groups 1-3), after medication for acute sinusitis (group 4), and after comprehensive treatment of chronic or fungal sinusitis (groups 5-6). Intraoperative and postoperative sinus-related complications were recorded.
RESULTS: Two patients (groups 1 and 3) developed acute rhinosinusitis after sinus augmentation; both recovered completely with medical treatment. Schneiderian membrane perforation occurred during sinus lift surgery in six patients (group 1): five recovered after conservative medical therapy and close observation, whereas one required endoscopic sinus surgery and recovered well. No chronic rhinosinusitis developed after dental implantation.
CONCLUSION: Craniofacial CT is crucial for pre-dental implantation sinonasal evaluation. The risk of dental implant-related chronic rhinosinusitis is low for patients with cysts, polyps, or mucosal thickening in the maxillary sinus. However, preventive endoscopic sinus surgery is recommended for patients with incurable chronic rhinosinusitis, fungal sinusitis, and large polyps or cysts. LEVEL OF EVIDENCE: 4. Laryngoscope, 128:1261-1267, 2018.
© 2017 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Dental implant; cone beam computed tomography; maxillary sinusitis; sinus augmentation

Mesh:

Year:  2017        PMID: 28921521     DOI: 10.1002/lary.26856

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  6 in total

Review 1.  Effect of Schneiderian Membrane Thickening on the Maxillary Sinus Augmentation and Implantation Outcomes: A Systematic Review.

Authors:  Reza Amid; Mahdi Kadkhodazadeh; Anahita Moscowchi; Majedeh Nami
Journal:  J Maxillofac Oral Surg       Date:  2021-04-02

2.  Air variability in maxillary sinus during radiotherapy for sinonasal carcinoma.

Authors:  M B Sharma; R Argota Perez; A I S Holm; S S Korreman; K Jensen; U V Elstrøm; C Grau
Journal:  Clin Transl Radiat Oncol       Date:  2021-01-01

Review 3.  Proposal for a Paradigm Shift in Personalized Medicine for Patients with a Maxillary Edentulous Jaw by ENT Specialist and Dentist Cooperation.

Authors:  Yuh Baba; Yasumasa Kato; Keiso Takahashi
Journal:  J Pers Med       Date:  2022-08-05

4.  Deep learning-based fully automatic segmentation of the maxillary sinus on cone-beam computed tomographic images.

Authors:  Hanseung Choi; Kug Jin Jeon; Young Hyun Kim; Eun-Gyu Ha; Chena Lee; Sang-Sun Han
Journal:  Sci Rep       Date:  2022-08-17       Impact factor: 4.996

Review 5.  Points to consider before the insertion of maxillary implants: the otolaryngologist's perspective.

Authors:  Sung Won Kim; Il Hwan Lee; Soo Whan Kim; Do Hyun Kim
Journal:  J Periodontal Implant Sci       Date:  2019-10-09       Impact factor: 2.614

6.  An Anatomic Study on the Maxillary Sinus Mucosal Thickness and the Distance between the Maxillary Sinus Ostium and Sinus Floor for the Maxillary Sinus Augmentation.

Authors:  Il Hwan Lee; Do Hyun Kim; Soo Whan Kim; Jun-Beom Park; Sung Won Kim
Journal:  Medicina (Kaunas)       Date:  2020-09-14       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.